SCHEMBL5659837

SCHEMBL5659837

Nc1cccc(CCNCCCCNCC(=O)Nc2ccc(Oc3ccccc3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.58
LTA4H P09960 5/20 0.56
KDM4E B2RXH2 2/20 0.52
HDAC1 Q13547 7/20 0.49
HDAC2 Q92769 4/20 0.49
RNF4 P78317 1/20 0.48
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
MITF O75030 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661172 0.88 RECQL (0.59) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5659647 0.88 LTA4H (0.62) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5658879 0.86 RECQL (0.56) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5661530 0.85 LTA4H (0.61) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL22069565 0.84 RECQL (0.75) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5661814 0.84 LTA4H (0.62) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5659377 0.83 LTA4H (0.63) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL22069745 0.82 RECQL (0.71) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5659737 0.82 LTA4H (0.62) RECQLLTA4HKDM4EHDAC1HDAC2
SCHEMBL5657528 0.80 TAAR1 (0.59) RECQLLTA4HKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase SCHERING AKTIENGESSELLSCHAFT (DE) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase LTA4H, LTB4R, LTC4S RECQL 161/4885LTA4H 1/4885KDM4E 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.